Key Events This Week
15 Jun: New 52-week and all-time high at Rs.87.90
16 Jun: Stock hits new 52-week and all-time high at Rs.92.00
17 Jun: Sharp decline begins with a 5.42% drop
19 Jun: Week closes at Rs.75.82, down 8.23%

Broad-Based Technical Strength Lifts Novelix Pharmaceuticals Ltd to 52-Week High of Rs 92
2026-06-16 09:42:32Surging past its previous peaks, Novelix Pharmaceuticals Ltd touched a fresh 52-week high of Rs 92 on 16 Jun 2026, marking a remarkable rally that has seen the stock gain nearly 197% over the past year, vastly outperforming the Sensex’s decline of 6.37% during the same period.
Read full news article
Broad-Based Technical Strength Lifts Novelix Pharmaceuticals Ltd to 52-Week High of Rs 87.9
2026-06-15 09:49:30Surging to an all-time high of Rs 87.9 on 15 Jun 2026, Novelix Pharmaceuticals Ltd has demonstrated remarkable price momentum, extending gains for nine consecutive sessions and delivering a 63.28% return over this period. This rally unfolds amid a broadly positive market backdrop, with the Sensex trading near its recent peaks.
Read full news articleNovelix Pharmaceuticals Ltd Gains 26.14%: 6 Key Factors Driving the Surge
2026-06-13 14:10:48
Key Events This Week
8 Jun: New 52-week high at Rs.71.00
9 Jun: All-time high reached Rs.78.94
12 Jun: New 52-week and all-time high at Rs.84.7
12 Jun: Stock closes week at Rs.82.62 (+26.14%)

Novelix Pharmaceuticals Ltd is Rated Hold
2026-06-12 10:10:05Novelix Pharmaceuticals Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article









